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Background: Timely diagnosis of dementia is a policy priority in the 
United Kingdom (UK). Primary care physicians receive incentives to 
diagnose dementia; however, 33% of patients are still not receiving a 
diagnosis. We explored automating early detection of dementia using 
data from patients’ electronic health records (EHRs). We investigated: 
a) how early a machine-learning model could accurately identify 
dementia before the physician; b) if models could be tuned for 
dementia subtype; and c) what the best clinical features were for 
achieving detection. 
Methods: Using EHRs from Clinical Practice Research Datalink in a 
case-control design, we selected patients aged >65y with a diagnosis 
of dementia recorded 2000-2012 (cases) and matched them 1:1 to 
controls; we also identified subsets of Alzheimer’s and vascular 
dementia patients. Using 77 coded concepts recorded in the 5 years 
before diagnosis, we trained random forest classifiers, and evaluated 
models using Area Under the Receiver Operating Characteristic Curve 
(AUC). We examined models by year prior to diagnosis, subtype, and 
the most important features contributing to classification. 
Results: 95,202 patients (median age 83y; 64.8% female) were 
included (50% dementia cases). Classification of dementia cases and 
controls was poor 2-5 years prior to physician-recorded diagnosis 
(AUC range 0.55-0.65) but good in the year before (AUC: 0.84). 
Features indicating increasing cognitive and physical frailty dominated 
models 2-5 years before diagnosis; in the final year, initiation of the 
dementia diagnostic pathway (symptoms, screening and referral) 
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explained the sudden increase in accuracy. No substantial differences 
were seen between all-cause dementia and subtypes. 
Conclusions: Automated detection of dementia earlier than the 
treating physician may be problematic, if using only primary care 
data. Future work should investigate more complex modelling, 
benefits of linking multiple sources of healthcare data and monitoring 
devices, or contextualising the algorithm to those cases that the GP 
would need to investigate.
Keywords 
Dementia, diagnosis, primary care, electronic patient records, early 
detection, machine learning.
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Introduction
Dementia is a global public health challenge and is one of the 
most common and serious disorders in the elderly population. 
The condition is characterized by progressive but often slow 
decline in memory, reasoning, communication and the ability to 
carry out daily activities. These symptoms can be caused by a 
number of illnesses that lead to structural and chemical changes 
in the brain, and death of brain tissue1. Currently there are no 
treatments which are curative for dementia; however, a timely 
diagnosis of dementia can still be valuable particularly for 
younger patients and their families, as they can be offered a range 
of supportive or therapeutic interventions, inform themselves 
about the condition, and plan for their future financial and care 
needs, which may help them maximize their quality of life2. For 
example, there is weak evidence that an early diagnosis followed 
by treatment with cholinesterase inhibitors may delay admission 
to institutionalised care3, although current available treatments do 
not impact long-term prognosis.
The United Kingdom (UK) Government published a National 
Dementia Strategy in 2009 in which earlier diagnosis was one 
of the key aims4. This was followed by the Prime Minister’s 
Challenge on dementia5 and the general practice focussed demen-
tia identification scheme6. These initiatives have brought the 
estimated rate of diagnosis up from 50% to around 67%7. Still, 
at the current time, one third of patients with dementia will 
not receive a recorded diagnosis for their condition in the UK’s 
National Health Service (NHS)7, and many patients still receive 
their diagnosis late in the disease course when many opportunities 
for improving quality of life may have passed.
In the UK NHS, 98% of the population is registered with 
general practitioner (GP) clinics, which provide the major-
ity of community-based generalist healthcare8. The early rec-
ognition of dementia, initiation of the diagnosis pathway, and 
follow-up medical care for people with dementia in the UK 
occurs in general practice, and GPs receive financial incentives 
for maintaining dementia registers and providing care.
All the information about a patient’s interactions with the general 
practice clinic, and with some other services within the NHS, is 
noted in an electronic record; each piece of clinical information 
entered also has a time stamp. This means that the patient’s record 
is a longitudinal account of their healthcare history. These longti-
tudinal healthcare accounts may differ systematically between 
patients who are developing dementia and those who are not, in 
the few years before dementia is identified. This has been found 
in studies which have manually examined patient notes. These 
studies found that cognitive symptoms, contact with social 
care professionals, unpredictable consulting patterns, increased 
attendance, levels of carer involvement, and changes to gait 
were higher in patients in the few years preceding the dementia 
diagnosis, compared to patients who were not developing 
dementia9,10.
In the UK, the government curates large datasets of NHS patient 
records. One such dataset of GP patient records is the Clinical 
Practice Research Datalink (CPRD), which GPs can opt to 
contribute to, and which holds data on over seven million 
current patients11,12. These databases form huge resources for 
health research, especially as the data contained in them goes 
beyond a list of clinical diagnoses, and includes social, adminis-
trative and lifestyle information, as well as tests performed and 
referrals made. With the time stamps in the data, the development 
of diseases, their determinants, and their outcomes can be tracked 
over time.
These records are used by medical researchers for studies on 
the distribution of disease in the population13–15, risk factors for 
disease16–19, and for examining drug safety in a community 
population20,21. Databases like CPRD could provide a valuable 
resource for understanding the onset and early presentation of 
disorders like dementia, and may provide a rich data source for 
creating early detection algorithms that can subsequently be 
developed into tools for automated decision or diagnostic sup-
port in primary care, which could help GPs to discuss, detect and 
label dementia in a more timely way, over and above current 
detection rates, if clinically indicated.
While recent reviews of dementia risk prediction models show 
a large body of research on methods to predict likelihood of 
dementia at a future point22,23, we found few studies that aimed 
to model automated methods to detect current, early dementia, 
especially in primary care or using only primary care data24,25. So 
far, there has been little investigation of how accurate an early 
detection model using only primary care data could be to pick 
up dementia, or how much earlier than current diagnosis by GPs 
a tool could discriminate well between patients who go on to be 
diagnosed and those who do not. The aim of this study was to 
explore different facets of the hypothesis that GP patient record 
data could be used to create an early detection tool for dementia. 
We aimed to ascertain whether patients with dementia could be 
discriminated from matched control patients, prior to recorded 
diagnosis, using only their recorded primary care data, and if so: 
1)     How early this discrimination could be achieved;
2)     Whether better discrimination could be achieved for 
dementia subtypes (Alzheimer’s and vascular dementia) 
based on different presentations, risk factors or symptoms 
patterns;
3)     What the most important features would be for 
achieving good discrimination at each of a number of 
time points prior to diagnosis and for each subtype.
Methods
Ethical statement
This study was approved by the Independent Scientific Advisory 
Committee at the Medicines and Healthcare Products Regulatory 
Authority, UK [15_111_R]. Pseudonymised data is collected by 
CPRD for future research purposes with an opt-in mechanism 
(consent) at the GP level, and an opt-out mechanism at the patient 
level; thus, patients can state their dissent for their data to be 
used for secondary purposes. Individual consent from patients is 
not required for this de-identified data re-use, the lawful basis for 
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this data processing under the General Data Protection Regula-
tion 2018 is legal obligation (direction from the Secretary of State 
for Health to extract data to carry out additional functions 
concerning: information functions, the information functions 
of any health or social care body and systems delivery func-
tions) and a task in the public interest (management of health and 
social care systems).
Data source
This study used data from the UK CPRD. CPRD was established 
in 1987, and now contains anonymized healthcare records from 
more than 19 million current and historic patients and represents 
13% of the UK population at any one time12. Patients are broadly 
representative of the UK general population in terms of age, sex 
and ethnicity. CPRD includes longitudinal observational data 
from GP electronic health record systems in primary care 
practices, including medical diagnoses (using Read codes), 
referrals to specialists and to secondary care, testing and 
interventional procedures conducted in primary care, lifestyle 
information (e.g. smoking, exercise) and drugs prescribed in 
primary care11. Data are captured using a structured hierarchical 
vocabulary called Read codes; these were developed by a UK GP, 
Dr James Read, in the 1980s to facilitate standardized assessment 
and semantic disambiguation of patient conditions when using 
computers. They map to other nomenclatures such as International 
Classification of Diseases (ICD), SNOMED-CT, and International 
Classification of Primary Care (ICPC) codes. Each Read code 
represents a term or short phrase describing a health-related 
concept. There are over 200,000 different codes, which are sorted 
into categories (diagnoses, processes of care and medication) 
and subchapters26. Each clinical entity is represented by an 
alphanumeric code and a Read term, which is the plain language 
description.
Study population
We constructed a case-control dataset. For this project, CPRD 
extracted the full records of patients with dementia (cases), 
identified on the basis of a code list for dementia diagnostic codes 
(general dementia, vascular and Alzheimer’s dementia codes) 
developed using code lists from Russell et al.27, and Rait et al.28, 
and used in Ford et al.24, (Appendix 1, see Extended data29). 
Patients had to be 65 years or older, and had to have records 
available in CPRD for at least three years prior to the first 
diagnosis code for dementia, which was recorded between 2000 
and 2012. All dementia patients meeting these criteria were 
extracted from the CPRD Gold database. Control patients were 
randomly sampled from patients who matched cases on year of 
birth, sex, and general practice, but had no dementia codes from 
the list anywhere in their record, and were also required to have 
at least three years of record prior to the matched “index date”. 
This resulted in not more than one match for each case; not all 
cases received a match. The entire available patient record was 
extracted for each patient. This resulted in 47,858 cases and 
47,663 controls.
Data management
The data were screened and processed using the following steps: 
firstly we removed cases who had no matched control (N = 195), 
then we removed the few controls who had a dementia code 
(N=7) and their matched case (N=7). Following slight adjust-
ment of our dementia code list to eliminate a code indicating only 
delirium (not dementia), we then removed cases who had no 
diagnostic dementia code (N=55) and their matched control 
(N = 55). This resulted in 47,601 cases and 47,601 controls. 
Only data from within the period five years before the index date 
were used. All data more than 5 years before, or at any time 
after, the index date were discarded. This was to standardise the 
sample, as fewer patients had data in each year over 5 years.
Sub-populations
For aim (2), tuning by dementia subtype, we specified three 
groups of patients:
1) All cause dementia; defined as all dementia cases, regardless 
of specificity of diagnosis (N = 47,601).
2) Alzheimer’s disease sub-group (N = 13,452); this was defined 
as cases with a code for Alzheimer’s disease; but no further codes 
for vascular dementia or any other specific dementia (e.g. Lewy 
Body), and no mixed Alzheimer’s and vascular. Cases were 
retained in the Alzheimer group if they had other unspecified codes 
for dementia e.g. “Senile Dementia Unspecified”. Each patient’s 
matched control was kept with them for analyses.
3) Vascular dementia sub-group (N = 10,870); this was defined 
as cases with a code for vascular dementia, but no evidence for 
Alzheimer’s disease, or mixed type. Cases were retained in the 
vascular group if they had other unspecified codes for dementia. 
Each patient’s matched control was kept with them for analyses.
There was no overlap between patients in the Alzheimer’s disease 
and Vascular dementia subgroups.
Feature selection
Because of the volume of different Read codes, and the fact 
that there are usually many Read codes representing the same 
clinical concept, we defined a wide list of clinical concepts or 
features a priori. We used two methods for selecting likely 
features. These were: 1) a systematic review and meta-analysis 
of existing literature from primary care records research on 
dementia30; and 2) a consultation of 21 GPs working as clinical 
tutors at the same institution as the authors, approached at two 
tutor meetings, with the following written question to provide clini-
cal grounding: “Please could you list anything you can think of 
which may frequently be entered in the patient record up to 
3 years before a dementia diagnosis (it does not have to be 
causal, just occur earlier in time than the diagnosis).” Responses 
were then handwritten as open free text answers on a sheet of 
paper and answers from all respondents were collated into a 
spreadsheet. The most common responses were: fall (suggested 
by six GPs); depression/low mood (eight GPs); anxiety (four 
GPs); cerebrovascular accident/transient ischaemic attack (six 
GPs); high blood pressure (five GPs); forgetful (five GPs); problem 
with memory (seven GPs); did not attend code (six GPs) (for full 
data on responses see Appendix 3, Extended data29). 
GP responses were mapped against clinical concepts found to be 
associated with dementia in the meta-analysis to create a final list 
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of features for the model. Features were operationalised by lists 
of Read codes. The features ranged from known or long-term 
risk factors for dementia (such as diabetes, smoking, or history 
of stroke), to health events related to general decline in health, 
mobility or cognition (such as infections, falls, burns and wound 
dressings), to GP activity around the dementia diagnostic process 
(such as memory loss codes, cognitive screening tests, blood tests, 
and referrals). We discarded suggested features such as “repeat 
consultations on the same thing” which could not be operation-
alised using a code list. Read code lists were sought for these 
predictors from an online code list repository31 and from email-
ing authors of reviewed studies. Where code lists for features were 
not readily available, new lists were drawn up using the CPRD 
medical dictionary application by author EF and checked by 
PR. This resulted in a total of 77 code lists. (Appendix 2, 
see Extended data29). Code lists were matched to event-level 
patient data. The five-year run up period was then split into 
five year-long sections. Binary features were created for each 
one-year time period, indicating whether a patient had ≥1 
instances of a code from each code list in that period. The crea-
tion of binary rather than count features is thought to reduce 
the effect of frequency of GP visits in the data25.
Analysis
Data were preprocessed and analysed using custom Perl scripts 
(Perl version 5.30) for data ingest, cleansing and reshaping, and 
Python scripts (Python version 3.7.4) employing the pandas, 
matplotlib and scikit-learn libraries for model training and 
evaluation, and plot generation (see Code availability)32.
Choice of algorithm. We chose a single method to run all 
analyses on particular subsets of the data by time, and by demen-
tia type (we term these “models”), as our aims were not to assess 
the effectiveness of different machine learning approaches. Studies 
suggest random forest algorithms are at least as good as and 
possibly better than conventional methods such as logistic 
regression and Cox proportional hazards regression for complex 
clinical prediction models when binary variables are used24,33,34. 
Our previous research suggested they performed similarly to 
neural networks and support vector machines on this data 
source24. They have the additional advantage that the list of fea-
tures that contribute to the final classification and their rela-
tive weights are readily available as a secondary output of the 
training procedure, giving an indication as to which elements 
of the patients’ EHRs contribute to the classification result 
most strongly. We used the Random Forest Classifier in scikit-
learn, with the number of “trees” in the “forest” set at 100. The 
“feature-importances” attribute in scikit-learn produces a set 
of estimates of importance of each feature in the random forest 
model whose values are positive and in total, the estimates for 
all features sum to 1.0. A normalized estimate of the predictive 
power of each feature is calculated from the fraction of sam-
ples a feature contributes to (related to how high up each tree 
the feature appears), combined with the decrease in impurity 
from splitting the samples. The higher the value given to each 
feature, the more important it is to the prediction35.
Assessment of accuracy. Using a fixed random number seed to 
ensure the same split of patients for each model, the data were 
split at random into 67% for training and 33% for testing. Each 
model was assessed for its ability to classify dementia cases 
versus controls using the Area Under the Receiver Operating 
Characteristic Curve (AUC) where an AUC of 0.5 indicates 
performance at chance, and an AUC of 1.0 indicates perfect 
classification of cases and controls36,37. A value of 0.7–0.8 is 
considered acceptable, 0.8–0.9 is considered good or very good, 
and 0.9 and above is excellent 36.
Fit of models to aims. To address aim (1), how early dementia 
can be detected by using data methods, the earliest point in time 
when detection of dementia could be achieved, models were run 
to examine discrimination in each of 5 years before diagnosis 
based on codes in that year and all previous years. In the Year -5 
model, only data from 5 years before diagnosis was included. In the 
Year -4 model, all data available prior to the end of the 4th year 
before diagnosis was included (year -5 and year -4). In the 
Year -3 model, data from years -3, -4 and -5 were included, for 
Year -2, data from years -2, -3, -4, and -5, and for Year -1, data 
from all years were included. The reasoning underpinning this 
approach was that we were looking to find the earliest time at 
which cases and controls could be well discriminated, using data 
which preceded that time period.
To address aim (2), to evaluate if models could be tuned to 
dementia subtypes, these same analysis models were run on 
the whole dataset (all cause dementia) and then on subsets of 
Alzheimer’s patients with their matched controls, and Vascular 
patients with their matched controls.
To address aim (3), to identify the most important features for 
achieving good discrimination at each of a number of time points, 
we generated lists of the features contributing most strongly to 
discrimination in each of these time periods and for each outcome 
(all cause dementia, Alzheimer’s and Vascular), and examined 




95,202 patients were included in the final analyses, these 
comprised 33,502 men (35.2%) and 61,700 women (64.8%). 
Patients had a median age of 83 years at index date (range 
65–110 years). All patients had at least three years’ worth of 
data, 90,351 patients (97.0%) had at least four years and 87,876 
patients (94.4%) at least five years.
For the 13,452 Alzheimer cases, there were 4,409 men (32.8%) 
and 9,043 women (67.2%); with median age of 82 years, (range 
65 -104), these retained their original matched controls with the 
same characteristics. For the 10,870 vascular dementia cases, 
there were 4,415 men (40.6%) and 6,455 women (59.4%); the 
median age was 83 years (range 65 – 103), and the equivalent in 
their matched controls.
Aim 1: When is the earliest that we can discriminate 
between cases and controls?
Using the 5 years of analysis and all specified predictive features, 
we found that discrimination between cases and controls was poor 
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(AUC range 0.55–0.65) in the 5 to 2 years prior to diagnosis, but 
showed slight but continuous improvement over this time. In the 
final year before diagnosis the model showed good discrimination 
(AUC: 0.84; Figure 1).
Aim 2: Can the model be tuned to achieve better 
discrimination for subtypes of Alzheimer’s disease or 
Vascular dementia?
Using the same set of features, very similar findings as for Aim 
1 were shown for the Alzheimer’s and Vascular subsets. In the 
final year before diagnosis the discrimination of the Alzheimer’s 
model was very good (AUC 0.89), and the Vascular model was 
also good (AUC 0.85). In years -2 to -5, the classifiers were poor 
to fair for both subsets (AUC 0.54–0.67) (Figure 2).
Aim 3: Examining the most important features for good 
discrimination
Inspecting the 15 most highly weighted features within each year 
block revealed that the increase in model performance over time 
was associated with a gradual shift in the types of codes recorded 
for patients over the time period examined (Table 1). Five years 
prior to diagnosis long term risk factors and progressive indicators 
of frailty and ill health predominated. From 4 years before 
current diagnosis, memory loss codes contributed more and more 
to the model, and by 2 years before this feature dominated all the 
other features. Only in the last year preceding diagnosis did 
action towards diagnostic underpinning become apparent with 
cognitive screening tests and referrals for further assessment 
becoming the most predictive features. The features most highly 
weighted in the models for the subsets of Alzheimer’s and Vascu-
lar dementia patients showed largely similar results (Table 2 and 
Table 3) although stroke and cardiovascular risk factors were 
more conspicuous among the most highly weighted predictors for 
Vascular dementia.
Discussion
We found that models discriminating between dementia cases 
and controls in the five-year period before diagnosis, using only 
information from primary care EHRs, were most successful in the 
final year before diagnosis, producing very good discrimination. 
This aligns with clinical intuition. Models performed similarly 
in the sub-groups of Alzheimer’s disease and Vascular dementia 
patients. However, we noted that the type of predictors most 
highly weighted in the model changed over time prior to 
diagnosis. At 5 years before diagnosis, known clinical risk 
factors such as smoking and cardiovascular risk factors were 
predictive alongside indicators that the patient was experiencing 
increasing health events such as visiting the hospital. During years 
4–2 before diagnosis, evidence of deterioration in general health, 
increase in frailty, and prodromal dementia symptoms were 
among the best predictors, which may be an indication of early 
symptoms of dementia becoming manifest, although memory 
loss symptoms were the top predictors in all these years. Finally, 
in the year before diagnosis, there was evidence of activity 
happening in primary care, which would lead the patient onto 
the pathway towards a dementia diagnosis, such as screening 
tests and referral. Good classification only became possible 
in this final year, when the patient was already being investi-
gated for dementia symptoms. Life-time dementia risk factors, 
and other clinical events such as accidents or infections, 
were not sufficient to offer very good discrimination between 
potential dementia cases and controls on their own. We found no 
Figure 1. Receiver operating characteristic (ROC) curves for random forest classifiers -5 to -1 years before diagnosis for all-cause 
dementia. AUC, Area Under the ROC Curve.
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Figure 2. Receiver operating characteristic curves (ROC) for random forest classifiers for dementia subtypes: Alzheimer’s disease 
(left) and vascular dementia (right). AUC, Area Under the ROC Curve.
Table 1. Most highly weighted features over time (all cause dementia).
Year -5 Year -4 Year -3 Year -2 Year -1
1 Infection (0.049) Memory loss codes 
(0.052)
Memory loss codes 
(0.071)
Memory loss codes 
(0.104)
Memory loss codes (0.223)
2 Is a smoker (0.044) Infections (0.046) Is a smoker (0.041) Is a smoker (0.037) Referral to Psychiatrist 




Is a smoker (0.043) Infections (0.039) Dressing of Wound 
Burn or Ulcer (0.035)
Cognitive Screening 
(MMSE) (0.040)
4 Memory loss codes 
(0.038)
Visit to Emergency 
Dept (0.037)









Infection (0.034) Did not attend code (0.023)
6 Dressing of wounds, 
burns or ulcer (0.035)
Dressing of wounds, 
burns or ulcer (0.035)
Urinary tract infection 
(0.034)
Visit to emergency 
dept (0.033)
Infections (0.023)
7 Hospital admission 
(0.035)
Urinary Tract Infection 
(0.034)
Antipsychotics (0.032) Urinary tract infection 
(0.031)
Is a smoker (0.023)
8 Urinary Tract Infection 
(0.034)
Deafness (0.030) Deafness (0.031) Antipsychotics (0.030) Hospital admission (0.022)
9 Visit to Emergency 
Dept (0.032)
GP Home visit (0.029) Visit to Emergency Dept 
(0.030)
Deafness (0.030) Visit to emergency dept 
(0.022)
10 Coronary Heart 
Disease (0.028)
Chronic kidney disease 
(0.028)




GP Home visit (0.022)
11 Hypertension (0.028) Antidepressants 
(0.028)
Hypertension (0.029) GP Home Visit (0.026) Urinary Tract infection 
(0.020)
12 Did not attend (0.026) Antipsychotics (0.027) GP Home visit (0.028) Antidepressant (0.025) Dressing of wound burn or 
ulcer (0.020)
13 Antipsychotics (0.026) Hypertension (0.027) Coronary Heart Disease 
(0.026)
Hypertension (0.024) Referral to memory 
assessment service (0.020)
14 Z-drugs (for insomnia) 
(0.025)
Did not attend (0.027) Did not attend (0.024) Did not attend (0.022) Constipation (0.020)
15 Deafness (0.024) Coronary heart disease 
(0.026)
Constipation (0.022) Coronary heart 
disease (0.021)
Had a fall (0.019)
Key: Red – long standing condition or risk factor; Orange – could be associated with increasing frailty or prodromal dementia symptoms; Green – General 
Practitioner has detected dementia symptoms.
Values for each predictor represent its relative contribution to the model compared to all other predictors (with all predictors together summing to 1.0, and a 
larger value being assigned to more important predictors; 77 predictors were included).
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Table 2. Most highly weighted features over time for Alzheimer’s disease.
Year -5 Year -4 Year -3 Year -2 Year -1
1 GP Home Visit (0.053) Memory loss codes 
(0.057)
Memory loss codes 
(0.080)
Memory loss codes (0.128) Memory loss codes (0.309)
2 Is a smoker (0.049) GP Home visit (0.050) GP Home visit (0.044) GP Home visit (0.041) Referral to Psychiatrist 
Neurologist or Geriatrician 
(0.080)
3 Infections (0.044) Infections (0.046) Visit to Emergency 
Dept (0.042)




4 Visit to Emergency 
Dept (0.043)
Visit to Emergency 
Dept (0.042)
Infections (0.038) Dressing of wound, burns 
or ulcer (0.035)
Referral to memory 
assessment service (0.030)
5 Dressing of wounds, 
burns or ulcer (0.038)
Is a smoker (0.041) Dressing of wound, 
burns or ulcer (0.036)
Is a smoker (0.034) Antidepressants (0.021)
6 Antipsychotics (0.038) Antipsychotics (0.038) Hospital admission 
(0.036)
Infections (0.033) Alzheimer-specific 
medication (0.021)
7 Memory Loss Codes 
(0.036)
Dressing of wounds, 
burns or ulcer (0.035)
Is a smoker (0.032) Hospital admission (0.032) Visit to Emergency Dept 
(0.019)






Antipsychotics (0.032) Did not attend (0.019)
9 Antidepressants 
(0.033)
Deafness (0.030) Urinary Tract Infection 
(0.033)
Deafness (0.029) Infections (0.018)
10 Urinary tract infection 
(0.031)
Chronic kidney disease 
(0.030)
Deafness (0.030) Urinary tract infection 
(0.028)
Hospital Admission (0.018)
11 Did not attend (0.031) Did not attend (0.029) Chronic Kidney 
Disease (0.027)
Did not attend (0.026) GP home visit (0.017)
12 Z-drugs (for insomnia) 
(0.028)
Urinary Tract Infection 
(0.027)
Did not attend (0.027) Chronic kidney disease 
(0.026)
Is a smoker (0.017)
13 Deafness (0.027) Constipation (0.026) Hypertension (0.025) Constipation (0.024) Cognitive Decline (0.017)




Falls (0.023) Hypertension (0.023) Urinary Tract Infection 
(0.017)
15 Constipation (0.024) Hypertension (0.023) Constipation (0.022) Antidepressants (0.022) Dressing of wound, burn or 
ulcer (0.016)
Key: Red – long standing condition or risk factor; Orange – could be associated with increasing frailty or prodromal dementia symptoms; Green – GP has 
detected dementia symptoms.
Values for each predictor represent its relative contribution to the model compared to all other predictors (with all predictors together summing to 1.0, and a 
larger value being assigned to more important predictors; 77 predictors were included).
substantial differences between predictors for Alzheimer’s or 
Vascular sub populations compared to all cause dementia.
Implications
The idea of using clinical decision support, populated only with 
routinely collected clinical data from primary care, with the aim 
of bringing forward dementia diagnosis to an earlier time point, 
seems challenging given these results. It would be interesting 
to discuss these findings further with local stakeholders to see 
whether this provides them with information that is helpful in 
clinical practice. Our findings suggest that while earlier risk 
factors, such as smoking or heart disease, may occur in higher 
rates in patients who go on to develop dementia, the differences 
in prevalence of these factors between individuals with dementia 
and those without may not be great enough, even when 
multiple conditions are combined, to discriminate between these 
populations. In addition, we found that our model only became 
accurate when evidence was accumulating in the record that the 
GP had themselves picked up on signs of dementia. This suggests 
that a simple binary classifier, using routinely collected clinical 
data from patient records, will struggle to outperform a clinician, 
given that these data are recorded by the clinician the algorithm 
is trying to support.
Strengths and limitations
We used data from over 95,000 real life patients treated in the 
NHS, collected in real time. This seems an adequate sample size 
for our purposes, and was made up of all patients available in 
the CPRD database who met our criteria, thus selection effects 
should be low. The external validity to the real world of our 
data is also high. However, because of the fact that these were 
‘real-life’ data, we know there may be misclassifications in the 
training data due to the fact that the data were not specifically 
collected for research but for care purposes. Their internal 
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Table 3. Most highly weighted features over time for vascular dementia.
Year -5 Year -4 Year -3 Year -2 Year -1
1 Infections (0.054) Infections (0.049) Infections (0.047) Memory loss codes 
(0.069)
Memory loss codes 
(0.169)
2 Dressing of wound, burn 
or ulcer (0.041)
Hypertension (0.042) Memory loss codes 
(0.045)
Infections (0.037) Referral to Psychiatrist 
Neurologist or Geriatrician 
(0.070)
3 Antidepressants (0.039) Dressing of wound, 
burn or ulcer (0.041)
Dressing of wound, 
burn or ulcer (0.037)




4 GP Home visit (0.038) Hospital admission 
(0.037)
Hypertension (0.037) Stroke (0.035) Stroke (0.037)
5 Did not attend (0.036) GP home visit (0.035) Hospital admission 
(0.036)
Hypertension (0.034) GP Home visit (0.033)
6 Hospital admission 
(0.035)
Visit to emergency 
dept. (0.035)
Is a smoker (0.035) GP home visit (0.033) Antidepressants (0.029)
7 Visit to Emergency dept. 
(0.033)
Is a smoker (0.033) Antipsychotics (0.033) Hospital admission 
(0.033)
Did not attend (0.025)
8 Stroke (0.032) Memory loss codes 
(0.032)
Visit to Emergency 
Dept. (0.033)
Did not attend (0.032) Falls (0.025)




GP Home Visit (0.032) Chronic Kidney disease 
(0.032)
Visit to emergency dept. 
(0.024)
10 Antipsychotics (0.031) Did not attend (0.032) Urinary Tract infection 
(0.032)
Visit to emergency dept 
(0.031)
Infections (0.024)
11 Deafness (0.030) Urinary Tract Infection 
(0.031)
Stroke (0.032) Is a smoker (0.031) Is a smoker (0.023)
12 Is a smoker (0.030) Antipsychotics (0.030) Chronic kidney 
disease (0.031)
Urinary tract infection 
(0.029)
Dressing of wound burn or 
ulcer (0.022)
13 Hypertension (0.029) Deafness (0.029) Did not attend (0.030) Deafness (0.029) Hospital admission (0.022)
14 Coronary Heart Disease 
(0.027)
Stroke (0.029) Deafness (0.030) Antidepressants (0.029) Hypertension (0.022)




Antipsychotics (0.028) Third party consultation 
(0.021)
Key: Red – long standing condition or risk factor; Orange – could be associated with increasing frailty or prodromal dementia symptoms; Green – General 
Practitioner has detected dementia symptoms.
Values for each predictor represent its relative contribution to the model compared to all other predictors (with all predictors together summing to 1.0, and a 
larger value being assigned to more important predictors; 77 predictors were included).
validity (or consistency across coders) may be low. However, 
we did not “clean” false negative cases out of our control sample. 
This is because we would have needed to use many of the features 
we used in our predictive model to identify these false negatives, 
thus leading to a form of incorporation bias. A further limitation 
is heterogeneity of clinic visits and timings of patients within the 
sample; for example, for those patients with very little data, our 
algorithm was unlikely make a good prediction, and this would be 
the same for an algorithm running in the clinic setting. It is also 
possible that control patients had less data or fewer visits, which 
could lead to bias in the model. Clinical coding in primary care, 
especially with an open and unstructured system like the Read 
codes (compared to the ICPC, for instance), necessarily picks up a 
lot of randomness38.
Given that age is the biggest known risk factor for dementia, and 
this was effectively eliminated from the model by the matched 
design, it is likely that future versions of the model would be 
improved by using a cohort design and incorporating age as a 
potential feature. Additionally, sex may be a useful predictor, given 
that rates of dementia are around twice as high in women as in 
men. It is possible that other predictors that we did not include, 
such as medication prescriptions, would also contribute to better 
discrimination. We were additionally restricted to information 
which is routinely gathered in primary care. Known risk factors 
such as APOE-4 genotype, low educational attainment, levels of 
physical activity and social isolation, and other potential cogni-
tive or neuro-psychiatric assessments are not well-captured in 
these records. Future studies that link research cohort and primary 
care data may be able to incorporate such additional risk factors 
and therefore improve the accuracy of predictive models.
A further limitation with our approach is that we only used 
data from the five years prior to diagnosis code or matched date. 
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This may have reduced the contribution of long-term conditions 
as features in the model, given that these may have been coded in 
patients’ records prior to the study period. Previous research using 
primary care records, and dementia risk prediction tools have 
found that chronic conditions such as diabetes, cardiovascular 
disease and depression are all likely increase future risk of 
dementia23,30. Of note in our study, smoking was an important 
feature throughout all models, and stroke and hypertension were 
among the top predictors for vascular dementia, which would 
be expected; however, the more transient or newly experienced 
indicators of developing frailty dominated the models. Additionally, 
the consideration of the differences between vascular and 
Alzheimer’s dementia is limited by their commonly occurring 
together as a mixed dementia.
Future research
While our model showed that there is some traction for this method 
perhaps in the year before diagnosis, it did not indicate a clear 
signal in primary care data that would advance the detection 
of dementia in the GP clinic to a point earlier in time; there are 
further avenues to explore. A recent policy report on dementia risk 
prediction models called for stratification of prediction models 
by different dementia subtypes, and also for modelling of change 
of behaviour or other features over time22. Given that dementia is 
characterised by progressive onset, a potential future avenue for 
automated decision support may be to identify patterns of behav-
iour or increase in morbidity or frailty over time. This approach 
would be strengthened by the linkage of multiple sources of 
healthcare data, for example from both primary and secondary 
care, as well as from wearable or monitoring devices, and by 
exploring more complex machine learning methods, perhaps with 
several methods running in series or in parallel. While a model 
based on signs and symptoms may not tell a clinician anything 
they do not already know, a model based on picking out 
characteristic patterns that develop over time, identified from 
several data sources, such as changes in gait or frailty10, may 
inform a clinician of an incipient problem that has been overlooked 
in a busy clinic.
Conclusions
We aimed to ascertain if cases of dementia could be discriminated 
from controls prior to diagnosis, to examine how early this 
discrimination could be achieved, and to uncover the best features 
for achieving good discrimination. We found predictive features 
evolved over time and the best discrimination was clearly 
achieved in the year before diagnosis when the features 
suggested that GPs were already cognisant of symptoms of the 
condition. If automated early detection were to be developed from 
routine clinical data, and for it to have clinical utility, we suggest 
modelling characteristic patterns of dementia onset over time, 
possibly from multiple sources of linked data. Such patterns 
could be missed by clinicians. Such risk modelling work should 
be embedded in a culture of stakeholder engagement, where 
clinicians and patients are consulted about their preferences for 
such an approach and can guide its implementation.
Data availability
Underlying data
The patient data that support the findings of this study are 
available from Clinical Practice Research Datalink (CPRD; 
www.cprd.com) but restrictions apply to the availability of these 
data, which were used under license for the current study, and so 
are not publicly available. For re-using these data, an application 
must be made directly to CPRD. Instructions for how to submit an 
application and the conditions under which access will be granted 
are explained at https://www.cprd.com/research-applications.
Extended data
Zenodo: Could dementia be detected from UK primary care 
patients’ records by simple automated methods earlier than by the 
treating physician? A retrospective case-control study - Extended 
Data. https://doi.org/10.5281/zenodo.386232529
-   Appendix 1 Dementia Code List.xlsx
-   Appendix 2 List of feature names.xlsx
-   Appendix 3 GP consultation full data.xlsx
Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC-BY 4.0).
Code availability
Source code available from: https://github.com/ASTRODEM/
detectability
Archived source code at time of publication: https://doi.org/ 
10.5281/zenodo.386300432
License: GNU Affero General Public License version 3 
(AGPL-3.0)
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CPRD and its longitudinal consistency. Efforts in the US are impeded by heterogeneity in practice 
patterns, record systems, and absence of a longstanding, national effort to improve detection and 
care of dementia in primary care. 
 
Particularly important in the design is the selection of medical record entry elements that 
practicing clinicians thought might be important early markers of dementia onset.  
 
One element I’d like to see in subsequent contributions from this group is dementia stage/severity 
at diagnosis in primary care - i.e. how ‘early’ did detection occur? 
 
Current thinking in the field - except in primary care - proceeds from the assumption that early 
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